Vimarsana
Biggest News Aggregation in the World

Activation Mediated News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Activation Mediated. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Activation Mediated Today - Breaking & Trending Today

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) - Vimarsana News

Sangamo Therapeutics to Present Neurology-Focused Pre-Clinical Data From Its Epigenetic Regulation, Capsid Delivery and Genome Engineering Platforms at the 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Published: April 22, 2024

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy has accepted 20 Sangamo abstracts for presentation at the 27th ASGCT Annual...

Source: marketscreener.com
Related Topics:
Kamy PoolerGreg DavisAmerican Society Of Gene Cell TherapyDevelopment Of BloodHead Of Research At SangamoDevelopment Of Modular Integrases MintsHead Of Technology At SangamoSangamo Therapeutics IncFormulation DevelopmentExchange CommissionSangamo TherapeuticsAmerican SocietyCell TherapyModular IntegrasesDravet SyndromeMeeting PresentationsCentral NervousNormal GeneProtein ExpressionHuman Disease ModelsHaploinsufficiency Using Zinc Finger ActivatorsZinc Finger Activator PlatformRestore Normal GeneCellular ModelsRepression Mediated
Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT) - Vimarsana News

Sangamo Therapeutics to Present Pre-Clinical Data Showcasing Its Epigenetic Regulation for Neurology and CAR-Treg Research at the 30th Annual Congress of the European Society of Gene & Cell Therapy (ESGCT)

Published: October 24, 2023

Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the European Society of Gene & Cell Therapy has accepted six Sangamo abstracts for presentation at the 30th Annual...

Source: marketscreener.com
Related Topics:
Bruxelles CapitaleJason FontenotExchange CommissionCongress PresentationsEuropean Society Of Gene Cell TherapySangamo Therapeutics IncSangamo TherapeuticsEuropean SocietyCell TherapyAnnual CongressChief Scientific OfficerFinger ActivatorsActivation MediatedZinc Finger ActivatorsTherapeutic ApproachPhelan Mcdermid SyndromeOligodendrocyte GlycoproteinChimeric Antigen ReceptorAnnual Report
Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT) - Vimarsana News

Sangamo Therapeutics, Inc.: Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Published: May 2, 2023

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the

Source: finanznachrichten.de
Related Topics:
Louise WilkieJason FontenotLos AngelesPlatform Development For ProductionAdministration In Cynomolgus MacaquesSangamo Therapeutics IncAmerican Society Of Gene Cell TherapyStrategic Formulation DevelopmentExchange CommissionSangamo TherapeuticsAmerican SocietyGene Cell TherapyChief Scientific OfficerMeeting PresentationsCentral NervousTherapeutic ApproachPainful Peripheral NeuropathiesPresentation MayExtend SurvivalAggressive Prion Disease ModelType Specific ReductionPrion ExpressionZinc Finger Protein DeliveryCross Corrective Epigenetic RegulationActivation Mediated